Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Opus Genetics, Inc.

NASDAQ: IRD · Life Sciences · 10 alerts · CIK 1228627

Share price
$4.04Close, Nov 16
Market cap
$390M
Shares outstanding
96.65MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Opus Genetics, Inc. filings on SEC EDGAR ↗

4:04 PM ET Form 4
Insider Selling

Opus Genetics CEO George Magrath Sells $110K of Stock

George Magrath, CEO, sold 28,258 shares of Opus Genetics, Inc. at $3.90 a share, worth $110K in total on Nov 3, 2026. Shares held after the trade: 2,010,636 (-1.4%).

Value
$110K
Shares
28,258
Price
$3.90
Role
CEO
Holding change
-1.4%
Trade date
Nov 3, 2026
4:48 PM ET Form 4
Insider Selling

Opus Genetics COO Joseph K. Schachle Sells $17K of Stock

Joseph K. Schachle, COO, sold 4,767 shares of Opus Genetics, Inc. at $3.56 a share, worth $17K in total on Oct 23, 2026. Shares held after the trade: 286,673 (-1.6%).

Value
$17K
Shares
4,767
Price
$3.56
Role
COO
Holding change
-1.6%
Trade date
Oct 23, 2026
4:41 PM ET Form 4
Insider Selling

Opus Genetics President Benjamin R. Yerxa Sells $117K of Stock

Benjamin R. Yerxa, President, sold 33,189 shares of Opus Genetics, Inc. at $3.53 to $3.55 a share (average $3.54) in 2 transactions, worth $117K in total on Oct 23, 2026. Shares held after the trade: 670,917 (-3.7%).

Value
$117K
Shares
33,189
Average price
$3.54
Role
President
Holding change
-3.7%
Trade date
Oct 23, 2026
4:29 PM ET Form 4
Insider Selling

Opus Genetics CFO Robert E. Gagnon Sells $49.6K of Stock

Robert E. Gagnon, CFO, sold 14,000 shares of Opus Genetics, Inc. at $3.55 a share, worth $49.6K in total on Oct 23, 2026. Shares held after the trade: 542,375 (-2.5%).

Value
$49.6K
Shares
14,000
Price
$3.55
Role
CFO
Holding change
-2.5%
Trade date
Oct 23, 2026
4:20 PM ET Form 4
Insider Selling

Opus Genetics CEO George Magrath Sells $34.4K of Stock

George Magrath, CEO, sold 9,591 shares of Opus Genetics, Inc. at $3.58 a share, worth $34.4K in total on Oct 23, 2026. Shares held after the trade: 2,038,894 (-0.5%).

Value
$34.4K
Shares
9,591
Price
$3.58
Role
CEO
Holding change
-0.5%
Trade date
Oct 23, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.